Phase 2 trial shows sorfequiline with pretomanid and linezolid may enhance TB treatment efficacy and safety for drug-sensitive patients.

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.

In a recent study published in the Journal of Infection, researchers performed a systematic literature review of global treatment outcomes of extensively drug-resistant Tuberculosis. The study found ...

The global tuberculosis drugs market is anticipated to witness massive growth during the forecast period (2021 to 2031). Tuberculosis is a chronic illness that has become a global health concern.

Cases of tuberculosis (TB) — an illness that kills more people than any other infectious disease — rose in the U.S. during 2022, per the Centers for Disease Control and Prevention (CDC). And some ...